Name: #504 OD: Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Start: 2021-06-17T12:00:00-0400
End: 2021-06-17T13:00:00-0400

Back To Schedule

#504 OD: Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans

Component Type: Session
Level: Intermediate

Having a product approved does not guarantee uptake post approval. This session will provide recommendations to insert evidence generating diagnostic strategies earlier in clinical development and will discuss case studies on different tactics.

Learning Objectives

Identify areas of opportunity to insert diagnostic strategies to generate real-world evidence into clinical development plans; Assess existing clinical development plans for new therapeutics and integrate evidence collection to support post approval product uptake.

Chair

Earl Seltzer, MBA

Speaker

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Patrick Short

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Keith Hanigan

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Jeffrey Shuster, PhD

Speakers

Earl Seltzer

Senior Director, Global Feasibility, Labcorp Drug Development, United States

Earl Seltzer has over 17 years of industry experience shared across clinical investigator sites in the United States and working at CROs in the strategic planning and feasibility space. At Labcorp, Mr Seltzer leads the global feasibility team as part of the larger, feasibility recruitment... Read More →

Beginner Intermediate
Tags Session

DIA 2021 Virtual Global Annual Meeting

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Earl Seltzer

Keith Hanigan

Patrick Short

Jeffrey Shuster